4//SEC Filing
METABASIS THERAPEUTICS INC 4
Accession 0001179110-09-001850
CIK 0001053221operating
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 6:25 PM ET
Size
17.1 KB
Accession
0001179110-09-001850
Insider Transaction Report
Form 4
Millican Trisha
Principal Accounting Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2009-01-29−20,250→ 0 totalExercise: $5.72Exp: 2016-08-31→ Common Stock (20,250 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-01-29−12,900→ 0 totalExercise: $7.35Exp: 2017-03-30→ Common Stock (12,900 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-01-29−10,750→ 0 totalExercise: $2.46Exp: 2018-02-01→ Common Stock (10,750 underlying) - Award
Stock Option (Right to Buy)
2009-01-29+50,565→ 50,565 totalExercise: $1.00Exp: 2019-01-29→ Common Stock (50,565 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-01-29−2,150→ 0 totalExercise: $2.00Exp: 2018-03-17→ Common Stock (2,150 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-01-29−4,515→ 0 totalExercise: $2.46Exp: 2018-02-01→ Common Stock (4,515 underlying)
Footnotes (7)
- [F1]The cancelled option provided for 25% of the shares to vest on the first anniversary of the grant date (8/31/06), and the remaining shares to vest in equal monthly installments over the following three years.
- [F2]The cancelled option provided for 25% of the shares to vest on the first anniversary of the grant date (3/30/07), and the remaining shares to vest in equal monthly installments over the following three years.
- [F3]The cancelled option provided for 25% of the shares to vest on the first anniversary of the grant date (2/1/08), and the remaining shares to vest in equal monthly installments over the following three years.
- [F4]The cancelled option provided for 100% of the shares to vest on the second anniversary of the grant date (2/1/08).
- [F5]The cancelled option provided for 25% of the shares to vest on the first anniversary of the grant date (3/17/08), and the remaining shares to vest in equal monthly installments over the following three years.
- [F6]The option provides for 25% of the shares to vest six months from the grant date (1/29/09) and the remaining 75% of the shares to vest in equal monthly installments over three years beginning on the grant date.
- [F7]Pursuant to the Company's Offer to Exchange Stock Options, on January 29, 2009, the Company cancelled options granted to the reporting person in exchange for new options equal to the number of shares under the cancelled options.
Documents
Issuer
METABASIS THERAPEUTICS INC
CIK 0001053221
Entity typeoperating
Related Parties
1- filerCIK 0001053221
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 6:25 PM ET
- Size
- 17.1 KB